Yifan Xinfu Pharmaceutical Co Ltd (002019) — Free Cash Flow Generation Index
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Free Cash Flow Generation Index of -3.60x as of September 2025. Free cash flow of CN¥-144.50 Million represents -4% of operating cash flow (CN¥40.18 Million). Explore Yifan Xinfu Pharmaceutical Co Ltd (002019) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see 002019 operating cash flow.
Annual Free Cash Flow Generation for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Yifan Xinfu Pharmaceutical Co Ltd. Check Yifan Xinfu Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | CN¥-100.87 Million | CN¥458.37 Million | CN¥559.23 Million | ▼ -1221.3% |
| 2024 | 0.02x | CN¥12.57 Million | CN¥640.73 Million | CN¥628.16 Million | ▲ +104.4% |
| 2023 | -0.45x | CN¥-155.50 Million | CN¥348.58 Million | CN¥504.09 Million | ▼ -199.9% |
| 2022 | -0.15x | CN¥-70.21 Million | CN¥472.07 Million | CN¥542.27 Million | ▲ +83.4% |
| 2021 | -0.90x | CN¥-270.51 Million | CN¥301.23 Million | CN¥571.74 Million | ▼ -353.4% |
| 2020 | 0.35x | CN¥392.80 Million | CN¥1.11 Billion | CN¥715.71 Million | ▲ +366.7% |
| 2019 | 0.08x | CN¥71.17 Million | CN¥937.24 Million | CN¥866.07 Million | ▼ -79.9% |
| 2018 | 0.38x | CN¥441.69 Million | CN¥1.17 Billion | CN¥729.21 Million | ▼ -33.9% |
| 2017 | 0.57x | CN¥646.87 Million | CN¥1.13 Billion | CN¥485.86 Million | ▼ -14.0% |
| 2016 | 0.66x | CN¥568.34 Million | CN¥855.85 Million | CN¥287.50 Million | ▲ +44.4% |
| 2015 | 0.46x | CN¥184.81 Million | CN¥401.96 Million | CN¥217.15 Million | ▲ +27.9% |
| 2014 | 0.36x | CN¥50.23 Million | CN¥139.74 Million | CN¥89.51 Million | ▼ -56.1% |
| 2013 | 0.82x | CN¥28.10 Million | CN¥34.32 Million | CN¥73.95 Million | ▲ +164.8% |
| 2012 | -1.26x | CN¥-37.76 Million | CN¥29.88 Million | CN¥67.64 Million | ▲ +20.1% |
| 2009 | -1.58x | CN¥-92.66 Million | CN¥58.61 Million | CN¥151.27 Million | ▼ -236.4% |
| 2008 | -0.47x | CN¥-39.15 Million | CN¥83.31 Million | CN¥122.46 Million | ▼ -252.5% |
| 2007 | 0.31x | CN¥76.64 Million | CN¥248.71 Million | CN¥172.06 Million | ▲ +140.2% |
| 2006 | -0.77x | CN¥-25.01 Million | CN¥32.62 Million | CN¥57.62 Million | ▲ +46.4% |
| 2005 | -1.43x | CN¥-34.51 Million | CN¥24.12 Million | CN¥58.63 Million | ▼ -31.5% |
| 2004 | -1.09x | CN¥-36.55 Million | CN¥33.59 Million | CN¥70.14 Million | ▲ +65.4% |
| 2003 | -3.14x | CN¥-39.78 Million | CN¥12.65 Million | CN¥52.44 Million | — |